Search

Your search keyword '"Hildebrand, F"' showing total 1,415 results
Start Over Author "Hildebrand, F"
1,415 results on '"Hildebrand, F"'

28. Structure and function of the global ocean microbiome

Author

Tara Oceans Coordinators, Sunagawa, S., Coelho, L. P., Chaffron, S., Kultima, J. R., Labadie, K., Salazar, G., Djahanschiri, B., Zeller, G., Mende, D. R., Alberti, A., Cornejo-Castillo, F. M., Costea, P. I., Cruaud, C., d'Ovidio, F., Engelen, S., Ferrera, I., Gasol, J. M., Guidi, L., Hildebrand, F., Kokoszka, F., Lepoivre, C., Lima-Mendez, G., Poulain, J., Poulos, B. T., Royo-Llonch, M., Sarmento, H., Vieira-Silva, S., Dimier, C., Picheral, M., Searson, S., Kandels-Lewis, S., Bowler, C., de Vargas, C., Gorsky, G., Grimsley, N., Hingamp, P., Iudicone, D., Jaillon, O., Not, F., Ogata, H., Pesant, S., Speich, S., Stemmann, L., Sullivan, M. B., Weissenbach, J., Wincker, P., Karsenti, E., Raes, J., Acinas, S. G., and Bork, P.

Published
2015

38. P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE CAR-HEMATOTOX SCORE

Author

Rejeski, K., primary, Blumenberg, V., additional, Hildebrand, F., additional, Frölich, L., additional, Karschnia, P., additional, Dreyling, M., additional, von Bergwelt-Baildon, M., additional, Schmidt, C., additional, Subklewe, M., additional, and Bücklein, V., additional

Published
2022
Full Text
View/download PDF

40. Gut microbiota dysbiosis in Parkinson's disease - a systematic review and pooled analysis

Author

Kleine Bardenhorst, S, Cereda, E, Severgnini, M, Barichella, M, Pezzoli, G, Keshavarzian, A, Desideri, A, Pietrucci, D, Aho V, T, Scheperjans, F, Hildebrand, F, Weis, S, Egert, M, Karch, A, Vital, M, Rübsamen, N, Kleine Bardenhorst, S, Cereda, E, Severgnini, M, Barichella, M, Pezzoli, G, Keshavarzian, A, Desideri, A, Pietrucci, D, Aho V, T, Scheperjans, F, Hildebrand, F, Weis, S, Egert, M, Karch, A, Vital, M, and Rübsamen, N

Published
2022

43. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations

Author

Sue, CM, Balasubramaniam, S, Bratkovic, D, Bonifant, C, Christodoulou, J, Coman, D, Crawley, K, Edema-Hildebrand, F, Ellaway, C, Ghaoui, R, Kava, M, Kearns, LS, Lee, J, Liang, C, Mackey, DA, Murray, S, Needham, M, Rius, R, Russell, J, Smith, NJC, Thyagarajan, D, Wools, C, Sue, CM, Balasubramaniam, S, Bratkovic, D, Bonifant, C, Christodoulou, J, Coman, D, Crawley, K, Edema-Hildebrand, F, Ellaway, C, Ghaoui, R, Kava, M, Kearns, LS, Lee, J, Liang, C, Mackey, DA, Murray, S, Needham, M, Rius, R, Russell, J, Smith, NJC, Thyagarajan, D, and Wools, C

Abstract

This document provides consensus-based recommendations for general physicians and primary care physicians who diagnose and manage patients with mitochondrial diseases (MD). It builds on previous international guidelines, with particular emphasis on clinical management in the Australian setting. This statement was prepared by a working group of medical practitioners, nurses and allied health professionals with clinical expertise and experience in managing Australian patients with MD. As new treatments and management plans emerge, these consensus-based recommendations will continue to evolve, but current standards of care are summarised in this document.

Published
2022

44. Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Author

Davis, RL, Kumar, KR, Puttick, C, Liang, C, Ahmad, KE, Edema-Hildebrand, F, Park, J-S, Minoche, AE, Gayevskiy, V, Mallawaarachchi, AC, Christodoulou, J, Schofield, D, Dinger, ME, Cowley, MJ, Sue, CM, Davis, RL, Kumar, KR, Puttick, C, Liang, C, Ahmad, KE, Edema-Hildebrand, F, Park, J-S, Minoche, AE, Gayevskiy, V, Mallawaarachchi, AC, Christodoulou, J, Schofield, D, Dinger, ME, Cowley, MJ, and Sue, CM

Abstract

BACKGROUND AND OBJECTIVES: Mitochondrial diseases (MDs) are the commonest group of heritable metabolic disorders. Phenotypic diversity can make molecular diagnosis challenging, and causative genetic variants may reside in either mitochondrial or nuclear DNA. A single comprehensive genetic diagnostic test would be highly useful and transform the field. We applied whole-genome sequencing (WGS) to evaluate the variant detection rate and diagnostic capacity of this technology with a view to simplifying and improving the MD diagnostic pathway. METHODS: Adult patients presenting to a specialist MD clinic in Sydney, Australia, were recruited to the study if they satisfied clinical MD (Nijmegen) criteria. WGS was performed on blood DNA, followed by clinical genetic analysis for known pathogenic MD-associated variants and MD mimics. RESULTS: Of the 242 consecutive patients recruited, 62 participants had "definite," 108 had "probable," and 72 had "possible" MD classification by the Nijmegen criteria. Disease-causing variants were identified for 130 participants, regardless of the location of the causative genetic variants, giving an overall diagnostic rate of 53.7% (130 of 242). Identification of causative genetic variants informed precise treatment, restored reproductive confidence, and optimized clinical management of MD. DISCUSSION: Comprehensive bigenomic sequencing accurately detects causative genetic variants in affected MD patients, simplifying diagnosis, enabling early treatment, and informing the risk of genetic transmission.

Published
2022

48. Indikationen und Interventionen für Damage Control Eingriffe: Systematisches Review und Expertenbefragung

Author

Pfeifer, R, Kalbas, Y, Halvachizadeh, S, Hildebrand, F, Osterhoff, G, Marzi, I, Lefering, R, and Pape, HC

Subjects
ddc: 610, MuST, Medicine and health, Polytrauma, Damage Control, Indikationen
Abstract

Fragestellung: Während die Damage Control (DC) Interventionen und Indikationen für thorakale und abdominelle Verletzungen aufgearbeitet und evaluiert worden sind, liegen zurzeit keine aktuellen Informationen für muskuloskelettale Traumata vor. Im Rahmen von einem systematischen Review [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2021
Full Text
View/download PDF

49. Die Häufigkeit von Revisionsoperationen ist höher nach Re-TEP im Vergleich zu ORIF nach periprothetischen Frakturen: Multizentrische Analyse an 156 Fällen Vancouver A, B und C

Author

Pflüger, P, Bolierakis, E, Wurm, M, Kanakaris, N, Giannoudis, P, Hildebrand, F, and Biberthaler, P

Subjects
ddc: 610, Periprothetische Fraktur, Hüftprothese, Femurfraktur, Medicine and health, Offene Reposition und interne Osteosynthese
Abstract

Fragestellung: Mit zunehmender Anzahl der implantierten Hüftprothesen in der letzten Dekade und dem demographischen Wandel ist die Inzidenz von periprothetischen proximalen Femurfrakturen (PPF) angestiegen. Die Versorgung stellt sowohl operativ als auch aufgrund der Komorbiditäten eine Herausforderung [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results